181 related articles for article (PubMed ID: 3262939)
1. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
Day RO; Williams KM; Graham S; Handel M
Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
Bird HA; Allen JG; Dixon JS; Wright V
Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of tenoxicam.
Nilsen OG
Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
[TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
Bird HA; Allen JG; Dixon JS; Wright V
Br J Rheumatol; 1985 Nov; 24(4):351-6. PubMed ID: 3877538
[TBL] [Abstract][Full Text] [Related]
6. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
Trnavská Z; Trnavský K; Zlnay D
Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with tenoxicam: a review.
Bird HA
Scand J Rheumatol Suppl; 1987; 65():102-6. PubMed ID: 3317799
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
[TBL] [Abstract][Full Text] [Related]
9. Tenoxicam: acute dose-dependent disposition studies in rats.
Lopez-Bustamante LG; Troconiz JI; Fos D
J Pharm Sci; 1993 Aug; 82(8):851-3. PubMed ID: 8377127
[TBL] [Abstract][Full Text] [Related]
10. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
Owen SG; Francis HW; Roberts MS
Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
[TBL] [Abstract][Full Text] [Related]
11. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.
Nilsen OG; Aasarød K; Widerøe TE; Guentert TW
Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981
[TBL] [Abstract][Full Text] [Related]
12. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly.
Bird HA; Francis RJ; Le Gallez P; Hill J; Dixon JS; Allen JG; Wright V
Eur J Rheumatol Inflamm; 1985; 8(1):60-9. PubMed ID: 3879831
[TBL] [Abstract][Full Text] [Related]
13. Plasma tenoxicam concentrations after single and multiple oral doses.
Crevoisier C; Heizmann P; Forgo I; Dubach UC
Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
[TBL] [Abstract][Full Text] [Related]
14. Overview on the pharmacokinetics of tenoxicam.
Guentert TW; Heintz RC; Joly R
Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107
[TBL] [Abstract][Full Text] [Related]
15. Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs.
Elmquist WF; Chan KK; Sawchuk RJ
Pharm Res; 1994 Dec; 11(12):1689-97. PubMed ID: 7899229
[TBL] [Abstract][Full Text] [Related]
16. Tenoxicam concentrations in synovium and joint cartilage in humans.
Bannwarth B; Netter P; Lapicque F; Mainard D; Fener P; Gillet P; Gaucher A
Agents Actions; 1991 Mar; 32(3-4):295-8. PubMed ID: 1862747
[TBL] [Abstract][Full Text] [Related]
17. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
[TBL] [Abstract][Full Text] [Related]
18. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
Deneke J; Luckow V; Guserle R; Pässler HH
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
[TBL] [Abstract][Full Text] [Related]
19. Single and multiple dose pharmacokinetics of tenoxicam in the elderly.
Nilsen OG; Walstad RA; Eckert M; Heizmann P; Bückert A; Am T; Løge I; Unnvik J; Thue E
Eur J Clin Pharmacol; 1988; 35(5):563-6. PubMed ID: 3266152
[TBL] [Abstract][Full Text] [Related]
20. Tenoxicam and ketoprofen level monitoring with high performance liquid chromatography in patients affected by rheumatoid arthritis.
Corvetta A; Della Bitta R; Luchetti MM; Pomponio G; Ciuffoletti V
Clin Exp Rheumatol; 1991; 9(2):143-8. PubMed ID: 2060161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
